DDIT3 and breast cancer: The activation of the PERK pathway leads to the upregulation of activating transcription factor 4 (ATF4), a transcription factor involved in amino acid metabolism [20], while elevated C/EBP homologous protein (CHOP) expression has been associated with enhanced cell death in certain breast cancer subtypes [21].